The pharmaceutical industry is undergoing major changes due to the advent of the new biologies, deeper understanding of the biology of diseases, the paucity of new chemical entities and blockbuster drugs coming off patent.

Pharmaceutical companies have to optimize their current portfolios through product marketing and repositioning.  In addition they have to think about identifying target patient populations using diagnostic and other tools to facilitate improved patient outcomes, faster market adoption and higher pricing.  We work with pharmaceutical companies by analyzing the best portfolio and indication flow, quantifying patient outcomes and economic impact through impact modeling and developing market entry strategies.  In addition, we analyze relevant literature and create marketing and sales tools.